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at our institution by noninvasive studies to assess for SND, atrioventricular block, and
atrial and ventricular arrhythmias. Assessment included an electrocardiogram, 24-hour
Holter monitor, and exercise stress test. Results: Twenty-nine children were evaluated at
a median age of 11years (range 6-19 years). Median age at TAPVC repair was 16 days
(range 1 – 141 days). Obstructed TAPVC occurred in 6 patients. Reoperation was per-
formed in 7 patients. EP data are presented in the table. 
One patient had 1st degree atrioventricular block and another patient had periods of 1st, 
2nd and 3rd degree atrioventricular block. Conclusion: TAPVC repair survivors appear 
to have a high incidence of SND and a low incidence of atrioventricular block in follow-up. 
Significant atrial and ventricular arrhythmias appear to be uncommon. Despite a 
favorable overall long-term outcome, these patients warrant ongoing clinical follow-up 
with arrhythmia surveillance
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Background: Risk factors including aortic atresia, ascending aorta size < 2.5 mm and
moderate to severe atrioventricular valve insufficiency (AVVI) have been associated with
higher interstage mortality after Norwood palliation for hypoplastic left heart syndrome.
Recently, routine interstage surveillance of oxygen saturation and weight has earlier
identified pathophysiology, led to early stage 2 palliation (S2P) and reduced interstage
attrition. This study sought to correlate anatomic and physiologic risk factors with adverse
interstage events (IE).
Method: Data from 51 consecutive patients who underwent stage one palliation (S1P)
were analyzed. S1P survivors were enrolled in an interstage surveillance program that
included prospective collection of daily weights and oxygen saturations. Patients with IE
defined as desaturation from baseline and/or poor weight gain were compared to those
patients without IE.
Results: Early survival following S1P for the cohort was 98% (50/51). Interstage survival
was 98% (49/50). Of S1P survivors, 27/50 (54%) demonstrated IE and 23/50 (46%)
patients had no IE. The single interstage death occurred in a patient with an interstage
event. Aortic atresia was the most common diagnosis for the cohort (40/50) and occurred
in 21/27 (78%) patients with IE and in 19/23 (83%) patients without IE (p=ns). The inci-
dence of ascending aorta size < 2.5 mm also was not statistically different between
groups: 9/27 (33%) patients with IE and 8/23 (35%) patients without IE. Demographic
data, perioperative hemodynamic data at S1P and AVVI following S1P were also similar
between groups. Patients with IE had urgent medical evaluation and underwent earlier
S2P when compared to those patients without IE: 3.5 ± 1.1 vs 5.0 ± 1.5 months
(p<0.001). S2P survival was 100% for both groups.
Conclusion: Previously identified risk factors for interstage mortality did not predict inter-
stage instability in this series of patients. Interstage surveillance identified patients at risk
for late attrition following S1P leading to earlier S2P in patients with IE. Given the lack of
predictive risk factors for IE, all patients who survive S1P should undergo routine inter-
stage surveillance.
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Louis Children's Hospital/Washington University School of Medicine, St. Louis, MO
Despite improvements in recent years, mortality following the Norwood procedure (NP)
remains excessive. It has been suggested that a learning curve can be developed for sur-
geons as well as institutions performing the procedure. The purpose of our study is to
more clearly define the role of institutional programs aimed at improving outcomes ver-
sus surgeon experience with the procedure. Our hypothesis is that institutional volume as
well as surgeon experience plays an important role in improved outcome following the
NP. Methods: We used abstracted hospital discharge data from the Pediatric Hospital
Information System(PHIS) database. Using this database we identified newborns from
1998-2001 admitted with hypoplastic left heart syndrome(HLHS). The number of NP and
the number of unique surgeons who performed at least one NP at each hospital were
recorded. Stepwise multiple regression analysis was used to look for an association
between case volume and rate of mortality.Results: 29 hospitals performed at least one
NP during the period examined. Institutions were categorized based on their 3 year NP
volume; low, <16 total procedures; medium, 16-30; high, >30). There were 9 hospitals in
the low volume category, and 10 in each the medium and high categories. The number of
unique NP surgeons ranged from 1-6 per institution with the mean SD at each volume
category being 2.1 1.3 at low volume, 2.4 1.4 at medium, and 3.4 1.6 at each high vol-
ume centers. Data analysis revealed that lower mortality following the NP was associated
with high institutional volume (p=0.02) but not with the number of unique NP surgeons
within the institution (p=0.13). Neither the institutional nor surgeon volume was associ-
ated with average length of stay in survivors or the time to mortality in non-survivors.
Conclusions: Mortality following the NP is associated with institutional NP procedure
volume, but not with individual surgeon NP case volume. These results emphasize the
importance of improvements in institutional-based approaches to the care of children
with HLHS.
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William L. Border, George H. Swingler, Thomas R. Kimball, Cincinnati Children's Hospital 
Medical Center, Cincinnati, OH
Background: Despite numerous recent technological advances in echo, there has been
little re-assessment of its diagnostic ability. Our purpose was to evaluate the diagnostic
accuracy of transthoracic echo by cardiac anatomic region in children with heart disease.
Methods: The findings from consecutive patients undergoing cardiac catheterization
and/or cardiac surgery from 1998 to 2003 at a single institution, were compared to pre-
procedural echocardiography. Twelve different anatomic regions were systematically
assessed.
Results: Data were collected on 1,982 patients. Sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) of echo are presented below: 
Specificity was excellent for all anatomic segments. Sensitivity was relatively poor for
anomalies of the systemic veins and coronary arteries, and the presence of collateral
vessels. Some of the commoner missed diagnoses were LSVC to the coronary sinus,
PAPVR to the SVC, and aberrant right subclavian artery.
Conclusion: Overall, pediatric transthoracic echocardiography has good specificity and
negative predictive value. However, sensitivity and positive predictive value are more
variable. This is especially evident when assessing systemic and pulmonary veins, coro-
nary artery anatomy, and branch pulmonary arteries. Clinicians need to be cognizant of
these limitations when interpreting echo results, and echocardiographers need to exam-
ine ways to improve this.
SND  Arrhythmia
Atrial Ventricular
SB, JR, EAR 14/29 
(48%)
Rare PAC 16/29 
(55%)
Rare PVC 17/29 
(59%)
Chronotropic 
impairment*
6/25 
(25%)
Occasional 
PAC
1/29 
(3%)
Frequent PVC 1/29 
(3%)
Pause > 2.0 s 3/29 
(10%)
Atrial couplets 2/29 
(7%)
Ventricular 
couplets
2/29 
(7%)
Non-Sustained 
SVT
1/29 
(3%)
Ventricular 
triplets
2/29 
(7%)
EAR, ectopic atrial rhythm; PAC, premature atrial complex; PVC, premature ventricular 
complex; JR, junctional rhythm; SB, sinus bradycardia; SND, sinus node dysfunction.
Rare = <1%; occasional = 1-5 %; frequent = > 5%.
* 8 pts had submaximal exercise performance.
Sensitivity (%) Specificity (%) PPV NPV
Pulmonary Veins 66.7 99.9 96.6 99.3
Systemic Veins 51.2 99.9 95.5 98.9
Atrial Septum 98.0 99.9 99.7 99.6
AV Valves 97.7 99.9 99.2 99.7
Ventricular Septum 98.9 99.7 99.1 99.7
Semilunar Valves 98.3 99.8 99.2 99.6
Central PA 98.4 99.8 98.8 99.8
Branch PA’s 74.1 99.5 86.3 98.9
Coronary Arteries 45.8 99.5 55.0 99.3
PDA 97.8 99.8 96.7 99.9
Aortic Arch 83.1 99.5 94.6 98.2
Collateral Vessels 35.5 100 100 98.9
